At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,161 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective Observational Long-term Safety Registry of Multiple Sclerosis Patients Who Have Participated in Cladribine Clinical Studies (PREMIERE)
In Brief
An observational study for Multiple Sclerosis. Completed, enrolled 1,161 participants across 1 site.
Detailed Summary
Prospective Observational Long-term Safety Registry of Multiple Sclerosis Participants who Have Participated in Cladribine Clinical Trials
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMultiple Sclerosis
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedNov 2009
Enrollment StartNov 2009
Primary CompletionOct 2018
TodayJul 2026
First PostedNov 13, 2009
Enrollment StartNov 30, 2009
Primary CompletionOct 25, 2018
TodayJul 2, 2026
Enrollment to primary: 8.9 yearsPosted 16.6 years ago